B
SGYP

Bailard’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bailard’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-115,500
Closed -$322K – 262
2014
Q3 		$322K Hold
115,500
– – 0.05% 171
2014
Q2 		$470K Hold
115,500
– – 0.07% 135
2014
Q1 		$613K Sell
115,500
-229,767
-67% -$1.29M 0.1% 115
2013
Q4 		$1.92M Hold
345,267
– – 0.31% 50
2013
Q3 		$1.56M Hold
345,267
– – 0.3% 55
2013
Q2 		$1.47M Buy
+345,267
New +$1.73M 0.27% 80

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Bailard's SGYP Position: Q4 2014 in Review

Bailard sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2014, closing a stake of 115,500 shares — an estimated $322K sold.

Bailard first reported a position in SGYP in Q2 2013 and held it in 6 quarters. The position peaked at $1.92M in Q4 2013. 78 funds tracked by Wall St. Rank hold SGYP as of Q4 2014.

  • Bailard reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2014 after selling out during the quarter.
  • Bailard sold 115,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2014, an estimated $322K.
  • Bailard first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 6 quarters.
  • Bailard's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.92M in Q4 2013.
  • 78 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2014.

Based on Bailard's 13F filing for Q4 2014, filed 26 Jan 2015.